Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 67%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT has substantially expanded its structured finance portfolio from $15 million to $871 million since early 2022, enhancing its operator relationships and diversifying yield. The company benefits from a favorable supply/demand disconnect in the healthcare real estate market, evidenced by a robust 22% same-store NOI growth among similarly positioned REITs over the past two years, with expectations for continued growth over the next five years. CareTrust's portfolio optimization efforts and management's improved capacity to deploy capital efficiently position the company favorably as tenant credit concerns have stabilized.

Bears say

CareTrust REIT's outlook is negatively affected by a lowered growth forecast, which is projected to lead to a decline in cash collections by approximately 5% and a slowdown in investment activity to around $1.0 billion. Increasing competition in the real estate market may drive property prices higher, potentially squeezing profitability and creating challenges for rent collection, especially in light of regulatory pressures such as the CA 525 bill that could impact tenant operators in California. Furthermore, the potential for new tenant issues and deteriorating conditions in capital markets may exacerbate liquidity problems, negatively influencing both cash investments and overall valuation in the healthcare real estate sector.

CareTrust REIT (CTRE) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 67% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 9 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.